2013 parkinson's disease glutathione 4 authors Dietary Antioxidants and Frontiers | Parkinson's disease models
Frontiers Parkinson's disease models and death signaling: what do we know until now? Parkinson's Disease: Current Treatment Modalities and Emerging Therapies PMC Parkinson's disease and glucose metabolism impairment Translational Neurodegeneration Springer Nature Link Gut microbiota and Parkinson's disease: exploring pathogenesis and potential therapeutic strategies from a gut brain axis perspective ScienceDirect G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis: Cell Reports Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Cell Death & Disease
Pay in 4 interest-free payments of $6.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





